In vivo delivery of bionanocapsules displaying Phaseolus vulgaris agglutinin-L4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase V

Human Gene Therapy

Volumn 19, Issue 9, 2008, Pages 887-895

  Kasuya, Takeshi ^a   Jung, Joohee ^a,b   Kadoya, Hiroyasu ^a   Matsuzaki, Takashi ^a,b   Tatematsu, Kenji ^a   Okajima, Toshihide ^a   Miyoshi, Eiji ^a   Tanizawa, Katsuyuki ^a,b   Kuroda, Shun'Ichi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; COATSOME EL 01 D; DNA; HEPATITIS B SURFACE ANTIGEN; ISOLECTIN L4; LIPOSOME; N ACETYLGLUCOSAMINYLTRANSFERASE; NANOCAPSULE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSENSOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLUORESCENCE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID BILAYER; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PHASEOLUS VULGARIS; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DNA, RECOMBINANT; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, NUDE; N-ACETYLGLUCOSAMINYLTRANSFERASES; NANOCAPSULES; NEOPLASM TRANSPLANTATION; NEOPLASMS; PHASEOLUS; PHYTOHEMAGGLUTININS; PHYTOTHERAPY; TRANSPLANTATION, HETEROLOGOUS;

PHASEOLUS VULGARIS;

EID: 51849157238     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.037     Document Type: Article

References (40)

1. Abdullaev, F.I., and De Mejia, E.G. (1997). Antitumor effect of plant lectins. Natural Toxins 5, 157-163.
2. Berting, A., Fischer, C., Schaefer, S., Garten, W., Klenk, H.D., and Gerlich, W.H. (2000). Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus. Virus Res. 68, 35-49.
3. Buckhaults. P., Chen, L., Freigen, N., and Pierce, M. (1997) Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J. Biol. Chem. 272, 19575-19581.
4. Chen, L., Zhang, W., Fregien, N., and Pierce, M. (1998). The Her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 17, 2087-2093.
5. Cummings, R.D., and Kornfeld, S. (1982). Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J. Biol. Chem. 257, 11230-11234.
6. Debbage, P.L., Griebel, J., Ried, M., Gneiting, T., De Vries, A., and Hulzler, P. (1998). Lectin intravital perfusion studies in tumor-bearing mice: Micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor. J. Histochem. Cytochem. 46, 627-639.
7. De Meyer, S., Depla, E., Maertens, G., Soumillion, S., and Yap, S.H. (1999). Characterization of small hepatitis B surface antigen epitopes involved in binding to human annexin V. J. Viral Hepat. 6, 277-285.
8. Dennis, J.S., Pawling, J., Cheung, P., Partridge, E., and Demetriou, M. (2002). UDP-N-acetylglucosamine:α-6-D-mannoside β1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice. Biochim. Biophys. Acta 1573, 414-422.
9. Dennis, J.W., Granovsky, M., and Warren, C.E. (1999). Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1473, 21-34.
10. Dosaka-Akita, H., Miyoshi, E., Suzuki O., Itoh, T., Katoh, H., and Taniguchi, N. (2004). Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin. Cancer Res. 10, 1773-1779.
11. Drummond, D.C., Meyer, O., Hong, K., Kirpotin, D., and Papahadjopoulos, D. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharm. Rev. 51, 691-743.
12. Fernandes, B., Sagman, U., Auger, M., Demetriou, M., and Dennis, J.W. (1991). β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 51, 718-723.
13. Geng, L., Osusuky, K., Konjeti, S., Fu, A., and Hallahan, D. (2004). Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay. J. Control. Release 99, 369-381.
14. Granovsky, M., Faya, J., Pawling, J., Mullar, J., Khokha, R., and Dennis, J.W. (2000). Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6, 306-312.
15. Hakomori, S. (1989). Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 52, 257-331.
16. Handerson, T., and Pawelek, J.M. (2003). β1,6-branched oligosaccharides and coarse vesicles: A common, pervasive phenotype in melanoma and other human cancers. Cancer Res. 63, 5363-5369.
17. Hobbs, S.K., Monsky, W.L., Yuan, F., Roberts, W.G., Griffith, L., Torchilin, V.P., and Jain, R.K. (1998). Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U.S.A. 95, 4607-4612.
18. Ihara, S., Miyoshi, E., Ko, J.H., Murata, K., Nakahara, S., Honke, K., Dickson, R.B., Lin, C.Y., and Taniguchi, N. (2002). Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1-6 GlcNAc branching. J. Biol. Chem. 277, 16960-16967.
19. Ireson, C.R., and Kelland, L.R. (2006). Discovery and development of anticancer aptamers. Mol. Cancer Ther. 12, 2957-2962.
20. Iwasaki, Y., Ueda, M., Yamada, T., Kondo, A., Seno, M., Tanizawa, K., Kuroda, S., Sakamoto, M., and Kitajima, M. (2007). Gene therapy of liver tumors with human liver-specific nanoparticles. Cancer Gene Ther. 14, 74-81.
21. Jung, J., Matsuzaki, T., Tatematsu, K., Okajima, T., Tanizawa, K., and Kuroda, S. (2008). Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J. Control. Release 126, 255-264.
22. Ko, J.H., Miyoshi, E., Noda, K., Ekuni, A., Kang, R., Ikeda, Y., and Taniguchi, N. (1999). Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. J. Biol. Chem. 274, 22941-22948.
23. Kuroda, S., Otaka, S., Miyazaki, T., Nakao, M., and Fujisawa, Y. (1992). Hepatitis B virus envelope L protein particles: Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J. Biol. Chem. 267, 1953-1961.
24. Marshall, E. (2006) Violent reaction to monoclonal antibody therapy remains a mystery. Science 311, 1688-1689.
25. Mehdi, H., Kaplan, M.J., Anlar, F.Y., Yang, X., Bayer, R., Sutherland, K., and Peeples, M.E. (1994). Hepatitis B virus surface antigen binds to apolipoprotein H. J. Virol. 68, 2415-2424.
26. Murata, K., Miyoshi, E., Kameyama, M., O. Ishikawa, Kabuto, T., Sasaki, Y., Hiratsuka, M., Ohigashi, H., Ishiguro, S., Ito, S., Honda, H., Takemura, F., Taniguchi, N., and Imaoka, S. (2000). Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin. Cancer Res. 6, 1772-1777.
27. Murata, K., Miyoshi. E., Ihara, Noura, S., Kameyama, M., Ishikawa, O., Doki, Y., Yamada, T., Ohigashi, H., Sasaki, Y., Higashiyama, M., Tarui, T., Takeda, Y., Kannagi, R., Taniguchi, N., and Imaoka, S. (2004). Attachment of human colon cancer cells to vascular endothelium is enhanced by N-acetylglucosaminyltransferase V. Oncology 66, 492-501.
28. Neurath, A.R., Kent, S.B., Strick, N., and Parker, K. (1986). Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 429-436.
29. Oess, S., and Hildt, E. (2000). Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther. 7, 750-758.
30. Portney, N.G., and Ozkan, M. (2006). Nano-drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 384, 620-630.
31. Raedler, A., and Schreiber, S. (1988). Analysis of differentiation and transformation of cells by lectins. Crit. Rev. Clin. Lab. Sci. 26, 153-193.
32. Schliemann, C., and Neri, D. (2007). Antibody-based targeting of the tumor vasculature. Biochim. Biophys. Acta 1776, 175-192.
33. Sinn, P.L., Sauter, S.L., and McCray, P.B., Jr. (2005). Gene therapy progress and prospects: Development of improved lentiviral and retroviral vectors: design, biosafety, and production. Gene Ther. 12, 1089-1098.
34. Tsutsui, Y., Tomizawa, K., Nagita, M., Michiue, H., Nishiki, T., Ohmori, I., Seno, M., and Matsui, M. (2007). Development of bionanocapsules targeting brain tumors. J. Control. Release 122, 159-164.
35. 4, the mitogenic isolectin of phytohemagglutinin. Mol. Biother. 2, 74-90.
36. 4 isolectin of PHA. Cancer Biother. Radiopharm. 12, 195-212.
37. Yamada, T., Iwabuki, H., Kanno T., Tanaka, H., Kawai, T., Fukuda, H., Kondo, A., Seno, M., Tanizawa, K., and Kuroda, S. (2001). Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein. Vaccine 19, 3154-3163.
38. Yamada, T., Iwasaki, Y., Tada, H., Iwabuki, H., Chuah, M.K., Vandendriessche, T., Fukuda, H., Kondo, A., Ueda, M., Seno, M., Tanizawa, K., and Kuroda, S. (2003). Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat. Biotechnol. 21, 885-890.
39. Yamashita, K., Tachibana, Y., Ohkura, T., and Kobata, K. (1985). Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J. Biol. Chem. 260, 3693-3969.
40. Zurita, A.J., Arap, W., and Pasqualini, R. (2003). Mapping tumor vascular diversity by screening phage display libraries. J. Control. Release 91, 183-186.